Cargando…
Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
BACKGROUND: Endoscopic and histological remission are both important treatment goals in patients with ulcerative colitis (UC). We aimed to define cellular architecture, expression of molecular markers, and their correlation with endoscopic scores assessed by ultra-high magnification endocytoscopy (E...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528147/ https://www.ncbi.nlm.nih.gov/pubmed/34019073 http://dx.doi.org/10.1093/ibd/izab059 |
_version_ | 1784586200859803648 |
---|---|
author | Iacucci, Marietta Jeffery, Louisa Acharjee, Animesh Nardone, Olga Maria Zardo, Davide Smith, Samuel C L Bazarova, Alina Cannatelli, Rosanna Shivaji, Uday N Williams, John Gkoutos, Georgios Ghosh, Subrata |
author_facet | Iacucci, Marietta Jeffery, Louisa Acharjee, Animesh Nardone, Olga Maria Zardo, Davide Smith, Samuel C L Bazarova, Alina Cannatelli, Rosanna Shivaji, Uday N Williams, John Gkoutos, Georgios Ghosh, Subrata |
author_sort | Iacucci, Marietta |
collection | PubMed |
description | BACKGROUND: Endoscopic and histological remission are both important treatment goals in patients with ulcerative colitis (UC). We aimed to define cellular architecture, expression of molecular markers, and their correlation with endoscopic scores assessed by ultra-high magnification endocytoscopy (ECS) and histological scores. METHODS: Patients with UC (n = 29) were prospectively recruited. The correlation among ECS score (ECSS), Mayo endoscopic score (MES), and histological scores were determined. Area under curve were plotted to determine the best thresholds for ECSS that predicted histological remission by Robarts (RHI) and Nancy Histological Index (NHI). Soluble analytes relevant to inflammation were measured in serum and mucosal culture supernatants using ProcartaPlex Luminex assays and studied by partial least square discriminant analysis and logistic model. Mucosal RNA sequencing and bioinformatics analysis were performed to define differentially expressed genes/pathways. RESULTS: Endocytoscope scoring system correlated strongly with RHI (r = 0.89; 95% CI, 0.51–0.98) and NHI (r = 0.86; 95% CI, 0.42–0.98) but correlated poorly with MES (r = 0.28; 95% CI, 0.27–0.70). We identified soluble brain-derived neurotrophic factors (BDNF), macrophage inflammatory proteins (MIP-1 α) and soluble vascular cell adhesion molecule 1 (sVCAM-1) predicted histological remission. Mucosal biopsy cultures also identified sVCAM-1 associated with healed mucosa. RNA-seq analysis identified gene expressions shared between ECSS, RHI, or NHI defined healing. A number of gene expressions and pathways were identified including inflammation and metabolic and tumor suppressors that discriminated healed from nonhealed mucosa. CONCLUSIONS: Endocytoscopy represents an interesting tool that may sit between endoscopy and histology—but closer to the latter—identifying gene expression markers and pathways that are also identified by histology. |
format | Online Article Text |
id | pubmed-8528147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-85281472021-10-20 Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission Iacucci, Marietta Jeffery, Louisa Acharjee, Animesh Nardone, Olga Maria Zardo, Davide Smith, Samuel C L Bazarova, Alina Cannatelli, Rosanna Shivaji, Uday N Williams, John Gkoutos, Georgios Ghosh, Subrata Inflamm Bowel Dis Leading Off BACKGROUND: Endoscopic and histological remission are both important treatment goals in patients with ulcerative colitis (UC). We aimed to define cellular architecture, expression of molecular markers, and their correlation with endoscopic scores assessed by ultra-high magnification endocytoscopy (ECS) and histological scores. METHODS: Patients with UC (n = 29) were prospectively recruited. The correlation among ECS score (ECSS), Mayo endoscopic score (MES), and histological scores were determined. Area under curve were plotted to determine the best thresholds for ECSS that predicted histological remission by Robarts (RHI) and Nancy Histological Index (NHI). Soluble analytes relevant to inflammation were measured in serum and mucosal culture supernatants using ProcartaPlex Luminex assays and studied by partial least square discriminant analysis and logistic model. Mucosal RNA sequencing and bioinformatics analysis were performed to define differentially expressed genes/pathways. RESULTS: Endocytoscope scoring system correlated strongly with RHI (r = 0.89; 95% CI, 0.51–0.98) and NHI (r = 0.86; 95% CI, 0.42–0.98) but correlated poorly with MES (r = 0.28; 95% CI, 0.27–0.70). We identified soluble brain-derived neurotrophic factors (BDNF), macrophage inflammatory proteins (MIP-1 α) and soluble vascular cell adhesion molecule 1 (sVCAM-1) predicted histological remission. Mucosal biopsy cultures also identified sVCAM-1 associated with healed mucosa. RNA-seq analysis identified gene expressions shared between ECSS, RHI, or NHI defined healing. A number of gene expressions and pathways were identified including inflammation and metabolic and tumor suppressors that discriminated healed from nonhealed mucosa. CONCLUSIONS: Endocytoscopy represents an interesting tool that may sit between endoscopy and histology—but closer to the latter—identifying gene expression markers and pathways that are also identified by histology. Oxford University Press 2021-05-21 /pmc/articles/PMC8528147/ /pubmed/34019073 http://dx.doi.org/10.1093/ibd/izab059 Text en © 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Leading Off Iacucci, Marietta Jeffery, Louisa Acharjee, Animesh Nardone, Olga Maria Zardo, Davide Smith, Samuel C L Bazarova, Alina Cannatelli, Rosanna Shivaji, Uday N Williams, John Gkoutos, Georgios Ghosh, Subrata Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission |
title | Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission |
title_full | Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission |
title_fullStr | Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission |
title_full_unstemmed | Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission |
title_short | Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission |
title_sort | ultra-high magnification endocytoscopy and molecular markers for defining endoscopic and histologic remission in ulcerative colitis—an exploratory study to define deep remission |
topic | Leading Off |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528147/ https://www.ncbi.nlm.nih.gov/pubmed/34019073 http://dx.doi.org/10.1093/ibd/izab059 |
work_keys_str_mv | AT iacuccimarietta ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT jefferylouisa ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT acharjeeanimesh ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT nardoneolgamaria ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT zardodavide ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT smithsamuelcl ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT bazarovaalina ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT cannatellirosanna ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT shivajiudayn ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT williamsjohn ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT gkoutosgeorgios ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission AT ghoshsubrata ultrahighmagnificationendocytoscopyandmolecularmarkersfordefiningendoscopicandhistologicremissioninulcerativecolitisanexploratorystudytodefinedeepremission |